SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRIS, Curis (formerly CBMI) -- Ignore unavailable to you. Want to Upgrade?


To: SemiBull who wrote (452)4/7/2003 7:50:11 PM
From: tuck  Read Replies (1) | Respond to of 668
 
Let's not get carried away:

Message 18806658

And note the date that the article was received for review was over 10 months ago. CRIS is still fishing for a partner, per their website, but if Erik's recollection that the company itself didn't think the intralesional injection approach was practical, I doubt a partner would, either. How many lesions would such a patient have? How many times would they have to be stuck? Results would have to be damn good to make it commercially acceptable, IMHO.

Cheers, Tuck